Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-23

Clinical Trial Update: Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase Ib/IIa drug-drug interaction trial evaluating a combination of 45 mg dextromethorphan with 105 mg bupropion for addiction and opioid use disor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)
  • bupropion (bupropion)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Addiction, Opioid Use | Phase 1, Phase 2 | Status: COMPLETED